Brief: Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting
28/04/2025 21:38
April 28 (Reuters) - Adicet Bio Inc ACET.O: ADICET BIO ANNOUNCES ORAL PRESENTATION HIGHLIGHTING PRECLINICAL ADI-270 DATA AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY (ASGCT) 28TH ANNUAL MEETING Source text: ID:nBw5P7c7ja Further company coverage: ACET.O (Reuters.Briefs@thomsonreuters.com)
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary